EUROIMMUN Logo
Find
X

What are you looking for?

Filter for products in our complete portfolio

Product finder

Worldwide
X
EUROIMMUN worldwide

This website provides an overview of the business activities and products of EUROIMMUN AG worldwide. Not all products are registered and approved in all countries or regions. Please contact your country representative for product availability and information

EUROIMMUN branches

Choose your country

Europe

North America

South & Central America

Asia

Middle East & Africa

EUROIMMUN Logo

Professional articles

by EUROIMMUN

ANTI-PLA2R ANTIBODY DETECTION IN PRIMARY MEMBRANOUS NEPHROPATHY: NOW RECOMMENDED BY KDIGO

Featured in Clinical Laboratory International

Autoantibodies against M-type phospholipase A2 receptors (PLA2Rab) are a central biomarker for diagnosis and monitoring of primary membranous nephropathy ...

PCR ALLOWS RAPID, DIFFERENTIATED DERMATOMYCOSIS DIAGNOSTICS

Featured in Clinical Laboratory International

The diagnosis of fungal infections of the skin and nails has undergone a paradigm shift in recent years. Traditional culturing methods have in many cases ...

TRACKING DOWN MYCOSES BY GENE DETECTION - NEW AND CLASSICAL PATHOGENS

Featured in Derm - Praktische Dermatologie

The spectrum of cutaneous mycoses and their pathogens is now more diverse and wide-ranging than ever before.

ANTI-PLA2R: A NON-INVASIVE SEROLOGICAL BIOMARKER IN LIEU OF BIOPSY

Featured in Omnia Health Magazine

Accurate diagnosis of the autoimmune kidney disease primary membranous nephropathy (pMN) is crucial for therapy decision-making. Autoantibodies against phospholipase ...

LABORATORY DIAGNOSTICS IN POLYCYSTIC OVARY SYNDROME

Featured in Omnia Health Magazine

Polycystic ovary syndrome (PCOS) is a common endocrine and reproductive disorder of women, which can result in menstrual complications, fertility problems and other ...

NEW AUTOMATION TECHNOLOGIES AT THE VANGUARD OF IFA DIAGNOSTICS

Featured in Clinical Laboratory International

EUROIMMUN has been creating innovative solutions for immunofluorescence diagnostics for over thirty years. Continuing this long tradition, the company ...

STANDARDISATION OF BIOMARKER MEASUREMENTS IN ALZHEIMER’S DISEASE DIAGNOSTICS

Featured in Omnia Health Magazine Jan/Feb 2022

Alzheimer’s disease is the most common cause of dementia in old age, accounting for 60 to 70 per cent of cases

MULTIPARAMETER AUTOANTIBODY TESTING IN AUTOIMMUNE NEUROLOGICAL DISEASES

Featured in Clinical Laboratory International

In recent years, there has been a growing understanding of the pathology of autoimmune neurological disorders, and the identification of the causal ...

Page 3 of 11.

Back to top